Medical devices cover an array products from consumable items to innovative implants and appliances, each serving a particular application or therapeutic area. The medical devices market has seen seismic changes with regional regulations, downwards pricing pressures and advancement in technological standards, equipment and procedures. A&M supports medical device companies in addressing critical objectives with our seasoned industry operators and results-driven approach.
To help deliver sustainable value creation, we support medical device companies and investors in the following areas:
- M&A Strategy, Carve-Outs & Synergy Capture
- Product Innovation & Launch
- Pricing & Reimbursements
- Business Unit / Model Re-design
- Product Margin Improvement
- Sales & Marketing Effectiveness
- Supply Chain Operations
- R&D and Portfolio Review
- Quality Control, Improvement & Compliance
- Regulatory Compliance
- Operating Cost & Working Capital Optimisation
We support a broad range of medical device developers, manufacturers and distributors, our experience covers the following specialist areas:
- Medical Imaging
- In-Vitro Diagnostics
- Orthopaedic Implants & Equipment
- Surgical Equipment & Supplies
- Aesthetic Devices
- Dental
- Ophthalmology
- ENT
- Distributors & Wholesalers
Why Private Equity Works in Value-Based Primary Care
February 2, 2026
Private equity’s influence in value‑based primary care is widely debated, but new evidence shows a different reality. This analysis gives healthcare leaders clarity on where disciplined capital strengthens care models, and where it doesn’t.
The State of Transformation for U.S. Healthcare Providers
January 26, 2026
Market dynamics for health systems are shifting. The most significant driver is the federal Medicaid mandate, which expired at the end of December 2025 and is now pending legislation. This uncertainty is prompting health system leaders to rethink strategy and operations. In this context, we’ll share how other health systems are responding and what these changes mean for organizations like yours.
Strategic Agility for Healthcare Leaders: Building Resilience Amid Disruption
January 12, 2026
The healthcare industry stands at a critical crossroads, grappling with an era of profound disruption and uncertainty. Over the past two decades, the pace of change has accelerated dramatically, reshaping the competitive landscape and challenging the ability of all stakeholders to adapt.
Provider-Sponsored Health Plans: Bridge or Anchor?
December 17, 2025
Provider-sponsored health plans are no longer neutral—they either create enterprise value or drain capital. This analysis gives CFOs and CEOs a clear framework to decide whether to scale, partner, restructure, or exit.
